High dose neostigmine treatment of malignant sinus tachycardia.
Sinus tachycardia caused by circulating catecholamines in the setting of congestive heart failure may impair systemic perfusion because of decreased diastolic filling time. We report the case of a patient with Wolff-Parkinson-White syndrome with angina and cardiogenic shock who improved dramatically following administration of neostigmine. Cardiac output, blood pressure, and stroke volume increased as heart rate was reduced. A previous attempt at heart rate control, in the same patient, using a low dose beta-antagonist, precipitated hemodynamic collapse. The remarkable recovery of our patient suggests that acetylcholinesterase inhibitors may warrant further investigation in patients with severe sinus tachycardia.
Schultheis
L W
LW
Department of Anesthesiology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Balser
J R
JR
Calkins
H
H
Robertson
S
S
Weiss
J L
JL
Sussman
M
M
Stuart
R S
RS
D000328:Adult; D002395:Catecholamines / Q000097:blood; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage*; D005260:Female; D006333:Heart Failure / Q000150:complications; D006801:Humans; D009388:Neostigmine / Q000008:administration & dosage*; D013616:Tachycardia, Sinus / Q000188:drug therapy* / Q000209:etiology
D002395:Catecholamines; D002800:Cholinesterase Inhibitors; D009388:Neostigmine